ES470690A1 - Un procedimiento para la produccion de nuevos derivados car-bostirilicos - Google Patents

Un procedimiento para la produccion de nuevos derivados car-bostirilicos

Info

Publication number
ES470690A1
ES470690A1 ES470690A ES470690A ES470690A1 ES 470690 A1 ES470690 A1 ES 470690A1 ES 470690 A ES470690 A ES 470690A ES 470690 A ES470690 A ES 470690A ES 470690 A1 ES470690 A1 ES 470690A1
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
cycloalkyl
hydrogen
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES470690A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES470690A1 publication Critical patent/ES470690A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
ES470690A 1977-06-10 1978-06-09 Un procedimiento para la produccion de nuevos derivados car-bostirilicos Expired ES470690A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体

Publications (1)

Publication Number Publication Date
ES470690A1 true ES470690A1 (es) 1979-10-16

Family

ID=27284068

Family Applications (2)

Application Number Title Priority Date Filing Date
ES470690A Expired ES470690A1 (es) 1977-06-10 1978-06-09 Un procedimiento para la produccion de nuevos derivados car-bostirilicos
ES479138A Expired ES479138A1 (es) 1977-06-10 1979-03-30 Un procedimiento para la produccion de nuevos derivados car-bostirilicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES479138A Expired ES479138A1 (es) 1977-06-10 1979-03-30 Un procedimiento para la produccion de nuevos derivados car-bostirilicos.

Country Status (21)

Country Link
US (1) US4298739A (enExample)
AR (2) AR224345A1 (enExample)
AT (1) AT367038B (enExample)
AU (1) AU510138B2 (enExample)
CA (1) CA1098907A (enExample)
CH (1) CH636087A5 (enExample)
DE (1) DE2825048A1 (enExample)
DK (1) DK149449C (enExample)
ES (2) ES470690A1 (enExample)
FI (1) FI69300C (enExample)
FR (1) FR2393795B1 (enExample)
GB (1) GB2002745B (enExample)
IE (1) IE46852B1 (enExample)
IT (1) IT1108326B (enExample)
MX (1) MX5527E (enExample)
NL (1) NL178074C (enExample)
NO (1) NO148813C (enExample)
NZ (1) NZ187452A (enExample)
PH (1) PH14670A (enExample)
PT (1) PT68157A (enExample)
SE (1) SE444562B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
JPS56122356A (en) 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
NZ211117A (en) * 1984-02-15 1987-10-30 Syntex Inc Fused tetrahydroimidazo-(2,1-b)quinazoline derivatives and pharmaceutical compositions
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
TW201305B (enExample) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
KR930702307A (ko) * 1991-08-23 1993-09-08 오오쓰까 아끼히꼬 카르보스티릴 유도체 및 혈소판 응집 억제제
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20080065704A (ko) 2005-11-09 2008-07-14 콤비네이토릭스, 인코포레이티드 의학적 이상의 치료 방법들, 조성물들, 및 키트들
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2196453A1 (en) * 2008-12-10 2010-06-16 Cellvir Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
BR112012003871A2 (pt) 2009-08-21 2015-09-08 Otsuka Pharma Co Ltd processo para a produção de composto de benzo[b][1,4]diazepina-2,4-diona
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103764672A (zh) 2011-03-01 2014-04-30 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
CN114404588A (zh) 2013-08-09 2022-04-29 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (enExample) * 1972-12-14 1977-10-03
JPS5234629B2 (enExample) * 1973-02-03 1977-09-05
SE431451B (sv) * 1973-10-24 1984-02-06 Otsuka Pharma Co Ltd Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
NL7806245A (nl) 1978-12-12
FI69300B (fi) 1985-09-30
AR224345A1 (es) 1981-11-30
ES479138A1 (es) 1979-07-01
DE2825048C2 (enExample) 1991-05-08
CA1098907A (en) 1981-04-07
IT7868355A0 (it) 1978-06-09
DE2825048A1 (de) 1978-12-14
IE46852B1 (en) 1983-10-05
DK254878A (da) 1979-02-09
SE7806710L (sv) 1978-12-11
US4298739A (en) 1981-11-03
NO782022L (no) 1978-12-12
ATA421378A (de) 1981-10-15
SE444562B (sv) 1986-04-21
DK149449B (da) 1986-06-16
FI781811A7 (fi) 1978-12-11
IT1108326B (it) 1985-12-09
GB2002745A (en) 1979-02-28
FI69300C (fi) 1986-01-10
DK149449C (da) 1986-11-24
NO148813B (no) 1983-09-12
AU510138B2 (en) 1980-06-12
AR225755A1 (es) 1982-04-30
NO148813C (no) 1983-12-21
FR2393795A1 (fr) 1979-01-05
AT367038B (de) 1982-05-25
NZ187452A (en) 1980-05-27
GB2002745B (en) 1982-02-17
MX5527E (es) 1983-09-23
IE781104L (en) 1978-12-10
PT68157A (en) 1978-07-01
AU3686678A (en) 1979-12-13
CH636087A5 (de) 1983-05-13
PH14670A (en) 1981-10-30
NL178074C (nl) 1986-01-16
FR2393795B1 (fr) 1986-07-25

Similar Documents

Publication Publication Date Title
ES479138A1 (es) Un procedimiento para la produccion de nuevos derivados car-bostirilicos.
SE7902794L (sv) Nya karbostyrilderivat och forfarande for framstellning derav
AU6128590A (en) Novel compounds
DE2960820D1 (en) Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them
ATE235476T1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
SE8006498L (sv) Karbostyrilderivat samt forfarande for framstellning av dem
SE8403801L (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
DE3661913D1 (en) Derivatives of 2,3-dihydro-benzofurane, processes for their preparation and pharmaceutical compositions containing them
AU598229B2 (en) Novel indenothiazole derivatives and process for their preparation
DE3879258D1 (de) Praeparat gegen ulcus.
EP0268990A3 (en) New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
SE8304071L (sv) Nya piperazinderivat
NO822948L (no) Analogifremgangsmaate for fremstilling av heterocykliske forbindelser.
EP0335979A4 (en) Thienopyrimidine derivatives
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
NZ332575A (en) Sulfonamide-substituted benzopyran derivatives, processes for preparation, medicament use and compositions comprising them
EP0383318A3 (en) Aralkylamine compounds
EP0347880A3 (en) Imidazo[2,1-b]benzothiazole compounds and antiulcer compositions containing the same
ATE29496T1 (de) Tetrahydro-beta-carbolin-derivate und verfahren fuer ihre herstellung.
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
IE801382L (en) Piperidines.
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
ES8602785A1 (es) Procedimiento para preparar derivados de pirazolpiridina
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
EP0461264A4 (en) Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204